Vera Therapeutics grants inducement equity awards to new chief regulatory officer, hires

Vera Therapeutics set inducement equity awards under its 2024 Inducement Plan for new hires in early August 2026.

Chief Regulatory Officer Nancy Bowman received options for 63,011 shares at $32.23, with 44,987 RSUs.

Two additional new employees received options for 5,600 shares at $29.95, with 2,800 RSUs.

Options vest over four years; 25% after year one, then monthly over 36 months, subject to continued service.

RSUs vest over four years; 25% each Aug. 20 anniversary, subject to continued service.